| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
6e-05 |